Necrolytic acral erythema

Source: Wikipedia, the free encyclopedia.
Necrolytic acral erythema
Other namesZinc-responsive necrolytic acral erythema[1]
SpecialtyDermatology

Necrolytic acral erythema is a cutaneous condition that is a manifestation of hepatitis C viral infection or zinc deficiency.[2] In the early stages, bullae, erosions, and erythematous or violaceous papules are its defining characteristics. Well-defined plaques with erythema on the outer rim, lichenification, secondary hyperpigmentation, and fine desquamation on the surface begin to appear in the late phase.[3]

Signs and symptoms

Traditionally, necrolytic acral erythema manifests as distinct, dark red hyperkeratotic plaques with a keratotic border that are usually found on the dorsum of the foot and toes. Ankles, legs, and knees may also be affected in some cases.[4] On occasion, lesions may appear on the buttocks, genitalia, hands, and elbows. It has been documented that the nails, palms, and soles, features typically thought of as distinguishing characteristics against necrolytic acral erythema, are affected.[5] Necrolytic acral erythema can show clinically as either acute or chronic. Flaccid blisters, erosions at the margins, and noticeable erythema are the symptoms of acute lesions. The hyperkeratotic surface, moderate erythema, and dark red border are seen in the chronic lesions. Edema may be present in conjunction.[4] The illness may have been present for two to one hundred and sixty months at the time of presentation.[6]

Three stages characterize the evolution of necrolytic acral erythema lesions: early, well-developed, and late. Scaly,

pustules.[4] In the later stages, the lesions become thinner, more confined, and more pigmented.[7] Lesions usually show a spontaneous remission and relapse pattern throughout time.[5]

Causes

As of yet, the precise etiology of necrolytic acral erythema remains unknown. Numerous causes, including hepatic dysfunction, hypoglucagonemia, hypoalbimunemia, hypoaminoacidemia, zinc deficiency, and diabetes with or without an underlying hepatitis C viral infection, have been postulated as part of the multifactorial pathophysiology of necrolytic acral erythema.[4]

Diagnosis

The biopsy site and illness stage are reflected in the histological characteristics. Early lesions from the margin display upper epidermal

Acanthosis, spongiosis, and a superficial dermal infiltration mimicking nummular dermatitis are observed in the epidermis. The well-developed lesions exhibit necrotic keratinocytes, psoriasiform hyperplasia, subcorneal pustules, significant papillomatosis, and parakeratosis. A fissure may occur in the top epidermis as a result of necrotic keratinocytes converging.[4]

Treatment

The most successful course of treatment to date has been oral zinc therapy.[4]

Epidemiology

Both sexes are equally affected by the illness; 46.2% of males and 53.8% of females are affected, respectively. Patients with necrolytic acral erythema fall into the 19–58 year age range, with a mean age of 44±11.3 and a median age of 50.[6]

See also

  • List of cutaneous conditions

References

  1. ^ RESERVED, INSERM US14-- ALL RIGHTS. "Orphanet: Zinc responsive necrolytic acral erythema". www.orpha.net. Retrieved 16 May 2019.{{cite web}}: CS1 maint: numeric names: authors list (link)
  2. .
  3. .
  4. ^ .
  5. ^ .
  6. ^ .
  7. .

Further reading

External links